Paraneoplastic Neurological Syndromes or Autoimmune EncephalitisSNPNCT05198661
Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis Collection
A study testing Collection of biological sample with sera, CSF, buffy coat, PBMC, plasma. in people with Paraneoplastic Neurological Syndromes or Autoimmune Encephalitis, run by Hospices Civils de Lyon at 62 sites in France.
Trial summary
Numerous neurological disorders affecting the central and peripheral nervous system can be attributed to the immune system through multiple effector mechanisms. However, current treatments could be drastically improved by faster and more accurate diagnosis. Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Paraneoplastic Neurological Syndromes or Autoimmune Encephalitis
- What is being tested?
- Collection of biological sample with sera, CSF, buffy coat, PBMC, plasma.
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 3,500 participants
- Where
- 62 sitesFrance
- Study dates
- 2 Aug 2022to 2 Aug 2032
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Who may be able to join
- Patient with consent
- Patient with well-characterized antibodies in serum or cerebrospinal fluid or not
- Patient with neurological disorder compatible with PNS or auto-immune encephalitis
Who cannot join
- Refusal of consent
- Patient under guardianship
Trial locations and contacts
62 sites in 1 country. Contact the study team or a site near you to ask about taking part.
62 sites in 1 country
France62 sites, 62 recruiting
- Not yet recruiting
Neurology
Aix-en-Provence, 13616
Laurent MARTINEZ ALMOYNA, MD, 04 42 33 50 71 ext. +33, lmartinezalmoyna@ch-aix.fr
Laurent MARTINEZ ALMOYNA, MD
- Not yet recruiting
Neurologie
Amiens, 80000
Melanie BARBAY, MD, Barbay.melanie@chu-amiens.fr
Melanie BARBAY, MD
- Not yet recruiting
Neurology
Angers, 49055
Lila Autier, MD, Lila.Autier@ico.unicancer.fr
Lila Autier, MD
- Not yet recruiting
General neurology
Annecy, 74370
Déborah GROSSET JANIN, MD, dgrossetjanin@ch-annecygenevois.fr
Déborah GROSSET JANIN, MD
- Not yet recruiting
Neurology
Avignon, 84000
Elodie BICILLI, MD, bicilli.elodie@ch-avignon.fr
Elodie BICILLI, md
- Not yet recruiting
Neurologie
Bayonne, 64100
Olivier FLABEAU, MD, oflabeau@ch-cotebasque.fr
Olivier FLABEAU, MD
- Recruiting
Neurology
Besançon, 25056
Nathalie Devys Meyer, MD, 0381667391 ext. 33, nmeyer@chu-besancon.fr
Nathalie Devys Meyer, MD
- Not yet recruiting
Neurology
Bobigny, 93000
Marie MONGIN, MD
Marie MONGIN, MD
- Not yet recruiting
Neurology
Bordeaux, 33000
Frederic VILLEGA, MD, 0556795626, frederic.villega@u-bordeaux.fr
Frederic VILLEGA, MD
- Not yet recruiting
Neurology
Brest, 29200
Serge TIMSIT, MD, 02 98 34 76 20 ext. 33, serge.timsit@chu-brest.fr
Serge TIMSIT, MD
- Not yet recruiting
Intensive care medicine
Cannes, 06400
Raphaël CHAMBON, MD, r.chambon@ch-cannes.fr
CHAMBON Raphaël, MD
- Not yet recruiting
Neurologie
Chambéry, 73011
Marie BARRE, MD, Marie.barre@ch-metropole-savoie.fr
Marie BARRE, MD
- Not yet recruiting
Neurology
Clermont-Ferrand, 63003
Eve CHANSON, MD, 0473752200 ext. +33, echanson@chu-clermontferrand.fr
Eve CHANSON, MD
- Not yet recruiting
Neurologie
Colmar, 68000
François SELLAL, md, 0389124150 ext. 33, francois.sellal@ch-colmar.fr
François SELLAL, MD
- Not yet recruiting
Neurology
Créteil, 94010
Thierry GENDRE, MD, 0149812303 ext. 33, Thierry.gendre@aphp.fr
Thierry GENDRE, MD
- Not yet recruiting
General, Vascular and Degenerative Neurology
Dijon, 21231
Yannick BEJOT, MD, 03 80 29 37 53 ext. 33, yannick.bejot@chu-dijon.fr
Yannick BEJOT, MD
- Recruiting
Neurology
Épinal, 88023
Arnaud LARDIN, MD, 03.29.68.71.04 ext. 33, arnaud.lardin@ch-ed.fr
Arnaud LARDIN, MD
- Not yet recruiting
Internal and general practitioner
Gap, 05000
Thierry WEITTEN, MD, 0492407680 ext. 33
WEITTEN Thierry, MD
- Recruiting
Neurologie
Grenoble
Martial MALLARET, MD, mmallaret1@chu-grenoble.fr
Martial MALLARET, MD
- Not yet recruiting
Neurology
La Roche-sur-Yon, 85925
Nathalie TESTARD, MD, nathalie.testard@ght85.fr
Nathalie Testard, MD
- Not yet recruiting
Neurology
Lille, 59000
Jean Paul NIGUET, MD, 0320874901 ext. 33, niguet.jeanpaul@ghicl.net
Jean Paul Niguet, MD
- Recruiting
Neurology
Lille
Tifanie ALBERTO, MD, tifanie.alberto@chu-lille.fr
Tifanie ALBERTO, MD
- Not yet recruiting
Neurology
Limoges, 87042
Laurent MAGY, MD, 05 55 05 65 61 ext. 33, Leurent.magy@unilim.fr
Laurent MAGY, MD
- Not yet recruiting
Neurology
Lisieux, 14100
Doina CIOCANU, MD, 0231613142 ext. 33, d.ciocanu@ch-lisieux.fr
Doina Ciocanu, MD
- Recruiting
Centre de référence des syndromes neurologiques paranéoplasiques et encéphalites autoimmunes
Lyon, 69677
Jerome HONNORAT, Pr, 4 72 35 78 06 ext. +33, jerome.honnorat@chu-lyon.fr
Jerome HONNORAT, Pr
- Not yet recruiting
Neurology
Mâcon, 71000
Patricia DEPIERRE, MD, padepierre@ch-macon.fr
Patricia DEPIERRE, MD
- Not yet recruiting
Adult Neurology and Neuropsychology
Marseille, 13005
Elsa KAPHAN, MD, elsa.kaphan@ap-hm.fr
Elsa KAPHAN, MD
- Not yet recruiting
Neurologie
Marseille, 13385
MAAROUF Adil, MD, 0491385939 ext. +33, Adil.maarouf@ap-hm.fr
MAAROUF Adil, MD
- Not yet recruiting
Neurology
Marseille
Hanna BOU ALI, MD
Hanna BOU ALI, MD
- Not yet recruiting
Neurology
Metz, 57085
Chrystel CHERAUD BONFORT, MD, c.cheraudbonfort@chr-metz-thioville.fr
Chrystel CHERAUD BONFORT, MD
- Not yet recruiting
Neurology
Montivilliers, 76290
Alexandre LECLANCHER, MD, 0686497074 ext. 33, alexandre.leclancher@ch-havre.fr
Alexandre LECLANCHER, MD
- Not yet recruiting
General Neurology
Montpellier, 34295
Mahmoud CHARIF, MD, m-charif@chu-montpellier.fr
Mahmoud CHARIF, MD
- Not yet recruiting
General medicine
Mulhouse, 68070
Sohrab MOSTOUFIZADEH, md, 0389646186 ext. 33, mostoufizadehs@ghrmsa.fr
Sohrab MOSTOUFIZADEH, MD
- Not yet recruiting
Neurologie
Nancy, 54035
Louise TYVAERT, MD, 03 83 85 85 85, l.tyvaert@chru-nancy.fr
Louise TYVAERT, MD
- Not yet recruiting
Neurology
Nantes, 44093
Hélène COURTEMANCHE, MD, 02 40 16 52 12 ext. 33, helene.courtemanche@chu-nantes.fr
Hélène COURTEMANCHE, MD
- Not yet recruiting
Neurologie
Nice, 06000
BOURG Véronique, MD, 04 92 03 82 80 ext. +33, Bourg.v@chu-nice.fr
BOURG Véronique, MD
- Not yet recruiting
Neurology
Nîmes, 30029
Giovanni CASTELNOVO, 466683261 ext. 33
CASTELNOVO Giovanni, MD
- Not yet recruiting
Neurology
Paris, 75014
Clément VIALATTE DE PEMILLE, MD, cvialatte@ghpsj.fr
Clément VIALATTE DE PEMILLE, MD
- Not yet recruiting
Neuropediatrics
Paris, 75015
Melodie AUBART, MD, melodie.aubart@aphp.fr
Melodie AUBART, MD
- Not yet recruiting
Intensive Care Medicine
Paris, 75018
Romain SONNEVILLE, MD, 0140256139 ext. 33, romain.sonneville@aphp.fr
Romain SONNEVILLE, MD
- Not yet recruiting
Neurology
Paris, 75019
Marine BOUDOT DE LA MOTTE, MD, 01 48 03 68 52 ext. 33, mboudotdelamotte@for.paris
Marine BOUDOT DE LA MOTTE, MD
- Not yet recruiting
Onco-neurology
Paris, 75651
Dimitri PSIMARAS, MD, 0142160435 ext. 33, dimitri.psimaras@aphp.fr
Dimitri PSIMARAS, MD
- Not yet recruiting
Neurology adult
Paris, 94275
Céline LABEYRIE, MD, 01 45 21 26 18 ext. 33, celine.labeyrie@aphp.fr
Céline LABEYRIE, MD
- Not yet recruiting
Neurology
Pointe à Pitre, Guadeloupe, 97159
Hugo CHAUMONT, MD, 5 90 89 14 30 ext. 590, hugo.chaumont@chu-guadeloupe.fr
Hugo CHAUMONT, MD
- Not yet recruiting
Neurology, neuropsychology and language rehabilitation
Poitiers
NEAU Jean-Philippe, MD, 06 08 22 42 31 ext. +33, jph.neau@chu-poitiers.fr
NEAU Jean-Philippe, MD
- Not yet recruiting
Neurology
Reims, 51100
Maximilien MOULIN, MD, 03 26 78 71 34 ext. 33, mmoulin@chu-reims.fr
Maximilien MOULIN, MD
- Not yet recruiting
Neurology
Rennes, 35000
Anca NICA, MD, anca.nica@chu-rennes.fr
Anca NICA, MD
- Not yet recruiting
Vascular and general neurology
Rouen, 76038
Benjamin HEBANT, MD
Benjamin HEBANT, MD
- Not yet recruiting
Neurology
Saint-Brieuc, 22000
Olivier VERCRUYSSE, MD
Olivier VERCRUYSSE, MD
- Not yet recruiting
Neurology
Saint-Denis, 93200
Mickael BONNAN, MD, 06 27 06 66 86 ext. 33, mickael_bonnan@yahoo.fr
Mickael BONNAN, MD
- Not yet recruiting
Neurology
Saint-Etienne, 42055
Jean-Philippe CAMDESSANCHÉ, MD, 0477120559 ext. 33, j.philippe.camdessanche@chu-st-etienne.fr
Jean-Philippe CAMDESSANCHÉ, MD
- Not yet recruiting
Neurologie
Saint-Nazaire, 44600
Lucie Metzger, MD, 0272278229 ext. 33, l.metzger@ch-saintnzaire.fr
Lucie Metzger, MD
- Not yet recruiting
Neurology
St-Malo, 35400
Alexandre Bonnet, MD, a.bonnet@ch-stmalo.fr
Alexandre Bonnet, MD
- Not yet recruiting
Neurologie
Strasbourg, 67098
Christine TRANCHANT, MD, 03 88 12 85 32 ext. +33, Christine.Tranchant@chru-strasbourg.fr
Christine TRANCHANT, MD
- Not yet recruiting
Neurology
Strasbourg, 67098
Edouard HIRSCH, MD, 03 88 12 85 62 ext. +33, edouard.hirsch@chru-strasbourg.fr
Edouard HIRSCH, MD
- Not yet recruiting
Neurology
Suresnes, 92150
Adrien WANG, MD, 0146257343 ext. 33, a.wang@hopital-foch.com
Adrien WANG, MD
- Not yet recruiting
Neurology
Toulon, 83100
Elena-Camelia Rusu, MD, 0616094863 ext. 33, Elena-camelia.rusu@ch-toulon.fr
Elena-Camelia RUSU, MD
- Not yet recruiting
Neurology
Toulon, 83800
Anthony FAIVRE, MD, 0483162726 ext. 33, anthonyfa@wanadoo.fr
Anthony FAIVRE, MD
- Not yet recruiting
Neurologie
Tours, 37000
Coline DUWICQUET, MD, 06 89 11 48 31 ext. +33, c.duwicquet@chu-tours.fr
Coline DUWICQUET, MD
- Not yet recruiting
Neurology
Valenciennes, 59300
Marianne GIROUX, MD, giroux-m@ch-valenciennes.fr
Marianne GIROUX, MD
- Not yet recruiting
Neurology
Vannes, 56000
Benoit PEGAT, MD, benoit.pegat@ch-bretagne-atlantique.fr
Benoit PEGAT, MD
- Not yet recruiting
Neurology
Versailles
Jérôme SERVAN, MD, 0139639147 ext. 33, jservan@ch-versailles.fr
Jérôme SERVAN, MD
About this study
Numerous neurological disorders affecting the central and peripheral nervous system can be attributed to the immune system through multiple effector mechanisms. However, current treatments could be drastically improved by faster and more accurate diagnosis. The sample collection will benefit to patients with rare neuroimmune syndromes such as Autoimmune Encephalitis (AE) and Paraneoplastic Neurological Syndromes (PNS) leading to a better and early diagnosis, as well as treatment improvement.
- Being tested
- Collection of biological sample with sera, CSF, buffy coat, PBMC, plasma.
- Keywords
- Paraneoplastic Neurological Syndromes, Autoimmune Encephalitis, biological collection
- Medical subject headings
- Autoimmune Diseases of the Nervous System
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Collection of biological sample with sera, CSF, buffy coat, PBMC, plasma.Biological
Blood is collected only one time by blood sample to obtain serum, buffy coat, plasma and PBMC.
2 *4ml of blood on dry tube 2 *4ml of blood on EDTA tube If possibility of delivery in 48 hours at the Centre of Biological Resources, 7*4ml of blood on heparin tube If cerebrospinal fluid has been drawn for diagnosis, remaining sample available will be stored in the collection
| Study group | Role | What they receive |
|---|---|---|
| Paraneoplastic neurological syndrome patients and autoimmune encephalitis patient | Other | patients with diagnosis of paraneoplastic neurological syndrome or autoimmune encephalitis Receives: Biological: Collection of biological sample with sera, CSF, buffy coat, PBMC, plasma. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Blood Samples
Assessment of biocollection of blood samples
Measured: 10 years
Cerebrospinal fluid biocollection
Assessment of biocollection of Cerebrospinal fluid
Measured: 10 years
Secondary outcomes (2)
Scientific collaboration
Number of project issued from the biocollection
Measured: 10 years
Scientific
Number of scientific papers issued from the biocollection
Measured: 10 years
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted20 Jan 2022
- Study start2 Aug 2022
- Primary completion2 Aug 2032 (estimated)
- Study completion2 Aug 2032 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Paraneoplastic Neurological Syndromes or Autoimmune EncephalitisStudies of the same condition, open and under way.
- More trials run by Hospices Civils de LyonThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Not applicable
- Intervention model
- Single group
- Model description
- Blood sample
- Masking
- None (open label)
- Enrolment
- 3,500 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Hospices Civils de Lyon
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05198661
- Sponsor's protocol ID
- 69HCL21_1271
- Acronym
- SNP
- Status last verified
- Feb 2024
- First submitted
- 20 Dec 2021
- Last updated
- 29 Feb 2024
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 29 Feb 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis Collection
- ClinicalTrials.gov ID
- NCT05198661
- Acronym / sponsor ID
- SNP / 69HCL21_1271
- Keywords
- Paraneoplastic Neurological Syndromes, Autoimmune Encephalitis, biological collection
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 3,500 participants (estimated)
- Lead sponsor
- Hospices Civils de LyonUniversity, hospital or other
- Study start
- 2 Aug 2022 (actual)
- Primary completion
- 2 Aug 2032 (estimated)
- Study completion
- 2 Aug 2032 (estimated)
- First posted
- 20 Jan 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Numerous neurological disorders affecting the central and peripheral nervous system can be attributed to the immune system through multiple effector mechanisms. However, current treatments could be drastically improved by faster and more accurate diagnosis. The sample collection will benefit to patients with rare neuroimmune syndromes such as Autoimmune Encephalitis (AE) and Paraneoplastic Neurological Syndromes (PNS) leading to a better and early diagnosis, as well as treatment improvement.
Study design
- Primary purpose
- Other
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
- Model description
- Blood sample
| Arm | Type | Receives |
|---|---|---|
| Paraneoplastic neurological syndrome patients and autoimmune encephalitis patient | Other | Biological: Collection of biological sample with sera, CSF, buffy coat, PBMC, plasma.patients with diagnosis of paraneoplastic neurological syndrome or autoimmune encephalitis |
Who may qualify
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
Key inclusion criteria (3 listed)
- Patient with consent
- Patient with well-characterized antibodies in serum or cerebrospinal fluid or not
- Patient with neurological disorder compatible with PNS or auto-immune encephalitis
Key exclusion criteria (2 listed)
- Refusal of consent
- Patient under guardianship
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Collection of biological sample with sera, CSF, buffy coat, PBMC, plasma.Blood is collected only one time by blood sample to obtain serum, buffy coat, plasma and PBMC. 2 *4ml of blood on dry tube 2 *4ml of blood on EDTA tube If possibility of delivery in 48 hours at the Centre of Biological Resources, 7*4ml of blood on heparin tube If cerebrospinal fluid has been drawn for diagnosis, remaining sample available will be stored in the collection | Biological | Paraneoplastic neurological syndrome patients and autoimmune encephalitis patient |
Primary outcome
Blood Samples
Time frame: 10 years
Assessment of biocollection of blood samples
Cerebrospinal fluid biocollection
Time frame: 10 years
Assessment of biocollection of Cerebrospinal fluid
2 secondary outcomes
Scientific collaboration
Time frame: 10 years
Scientific
Time frame: 10 years
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 29 Feb 2024.
- Individual participant dataSharing planned: Undecided
Related trials for Paraneoplastic Neurological Syndromes or Autoimmune Encephalitis
RecruitingEarly Phase 1
CD19/BCMA-Targeted UCAR-T for Patients With Neurological Autoimmune Diseases
Relapsing or Refractory Multiple Sclerosis (MS), Myasthenia Gravis (MG)
Active, not recruitingPhase 2
Autologous Stem Cell Transplant for Neurologic Autoimmune Diseases
Autoimmune Disease, Neurologic Autoimmune Disease
RecruitingObservational study
Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research
Post-Acute COVID-19 Syndrome, ME/CFS
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
62 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Collection of biological sample with sera, CSF, buffy coat, PBMC, plasma. in people with Paraneoplastic Neurological Syndromes or Autoimmune Encephalitis, run by Hospices Civils de Lyon at 62 sites in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 29 Feb 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 62 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Jerome HONNORAT, Pr (4 72 35 78 06 ext. +33, jerome.honnorat@chu-lyon.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Blood Samples (time frame: 10 years). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Feb 2024.